Centrillion Taiwan Raises Financing from ARM IoT Fund

Hsinchu, Taiwan– Centrillion Technologies Taiwan, an innovator in the development and commercialization of transformative genomic analysis tools announced today that it has received a strategic investment from the Arm IoT Fund. With this capital investment, Centrillion Taiwan will continue to expand its manufacturing subsidiary in Hsinchu, Taiwan.   As the largest chipset provider for big…

Centrillion Technologies Announces WeDoctor Partnership

Palo Alto, California – Centrillion Technologies, an innovator in building transformative genomic analysis tools announced that it has entered into a partnership with WeDoctor Holdings Limited (“WeDoctor”), China’s leading technology-enabled medical and healthcare solutions platform. The strategic cooperation agreement includes a multi-million US dollar investment by WeDoctor and establishes with Centrillion (Hangzhou) Co., Ltd. a…

Centrillion Technologies Adds Suzanne Dee as Vice President of Product Science

Palo Alto, California; March 17, 2016 – Centrillion Technologies, a leading genomic technology company developing and commercializing transformative genomic analysis tools, announced today that Dr. Suzanne Dee has joined the company as Vice President, Product Science. Dr. Dee brings over twenty years of product development experience in biotechnology, genomics and diagnostics.   “We are thrilled…

Centrillion Adds Vice President of Technology Research and Operations in Taiwan

 PALO ALTO, Calif., March 17, 2016 – Centrillion Technologies, a leading genomic technology company developing and commercializing transformative genomic analysis tools, has named Dr. Tzu Kun (TK) Ku as its Vice President of Technology Research and Operations for its subsidiary in Hsinchu Taiwan, R.O.C. Dr. Ku joins Centrillion from Taiwan’s Industry Technology Research Institute (ITRI)’s…

Centrillion expands executive team with new chief strategy officer

Palo Alto, California; May 11, 2015 – Centrillion Technologies, a leading genomic technology company developing and commercializing transformative genomic analysis tools, has named Dr. James Zhang as its new Chief Strategy Officer. Dr. Zhang, a geneticist turned entrepreneur and venture capitalist, will join the executive team with responsibilities in corporate strategy, strategic business development, investor…